Occurrence of MRSA endocarditis during linezolid treatment

被引:15
作者
Ben Mansour, EH
Jacob, E
Monchi, M
Ledoux, D
Canivet, JL
De Mol, P
Damas, P
机构
[1] Univ Hosp, Dept Gen Intens Care, B-4000 Liege, Belgium
[2] Univ Hosp, Dept Microbiol, B-4000 Liege, Belgium
关键词
D O I
10.1007/s10096-003-0959-6
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
[No abstract available]
引用
收藏
页码:372 / 373
页数:2
相关论文
共 5 条
[1]   Efficacy of linezolid in treatment of experimental endocarditis caused by methicillin-resistant Staphylococcus aureus [J].
Dailey, CF ;
Dileto-Fang, CL ;
Buchanan, LV ;
Oramas-Shirey, MP ;
Batts, DH ;
Ford, CW ;
Gibson, JK .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (08) :2304-2308
[2]   Oxazolidinone antibiotics [J].
Diekema, DJ ;
Jones, RN .
LANCET, 2001, 358 (9297) :1975-1982
[3]   Linezolid therapy of vancomycin-resistant Enterococcus faecium experimental endocarditis [J].
Patel, R ;
Rouse, MS ;
Piper, KE ;
Steckelberg, JM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (02) :621-623
[4]   SIMPLIFIED DOSING AND MONITORING OF VANCOMYCIN FOR THE BURN CARE CLINICIAN [J].
RICE, TL .
BURNS, 1992, 18 (05) :355-361
[5]   Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: A randomized, double-blind, multicenter study [J].
Rubinstein, E ;
Cammarata, SK ;
Oliphant, TH ;
Wunderink, RG .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (03) :402-412